Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Neglected Tropical Diseases (NTDs)

  • your selections
Clear Search

Filter Results

date

Area

Information Type

Organization/Initiative

Issue/Condition

  • results
State Department and USAID release a “Joint Summary of Performance and Financial Information for FY 2012″

The State Department and U.S. Agency for International Development (USAID) released a “Joint Summary of Performance and Financial Information for FY 2012” summarizing the performance and accomplishments of the two agencies in fulfilling their diplomatic and development objectives, including efforts to address global health issues.

Administration official discusses U.S. efforts to assist Least Developed Countries through the GHI and Feed the Future

In a statement before the Economic and Financial Committee (Second Committee) of the General Assembly of the United Nations, U.S. Deputy Representative to ECOSOC John Sammis summarized U.S. efforts to help reduce poverty and achieve the Millennium Development Goals (MDGs) through initiatives such as the Global Health Initiative (GHI) and Feed the Future (FtF).

White House releases FY 2011 Budget

The White House released the FY 2011 budget request, which included the following funding totals for the U.S. Global Health Initiative (GHI) and other global health and related activities:

Global Health Initiative (GHI) total: $9.572 billion, including

- $8.513 billion from State & Foreign Operations Global Health & Child Survival (GHCS) account, and

- $1.059 billion from HHS, DoD, and other State & Foreign Operations accounts.

- PEPFAR: Included in the GHI total is $6.990 billion for PEPFAR of which $1 billion is for the Global Fund ($700 million from the State Department and $300 million from HHS).

Additional funding details on the GHI and other global health related accounts:

State and Foreign Operations funding for global health:

- Global Health & Child Survival (GHCS): $8.513 billion
– USAID: $3.013 billion
– Maternal Health & Child Health/Nutrition: $900.0 million
– Maternal & Child Health: $700.0 million

- Nutrition: $200.0
– Vulnerable Children: $15.0 million

- HIV/AIDS: $350.0 million

- Family Planning/Reproductive Health: $590.0 million

- Other Infectious Diseases: $1,158.0 million, which includes
– Malaria: $680.0 million,

- Tuberculosis: $230.0 million ,

- Neglected Tropical Diseases (NTDs): $155.0 million,

- Pandemic Influenza and Other Emerging Threats: $75 million, and

- Other Public Health Threats: $18 million.
– Department of State: $5.500 billion
– HIV/AIDS: $5.500 billion (includes $700 million for the Global Fund)
– Millennium Challenge Corporation: $1.280 billion

Health and Human Services funding for global health:

- CDC ($351.9 total):
– Global AIDS Program: $118.1 million

- Global Immunization Program: $152.8 million

- Global Disease Detection: $37.8 million

- Global Malaria Program: $9.2 million

- Other Global Health: $35.1 million
– Global Fund: $300.0 million

- Fogarty International: $73.0 million

Administration releases Global Health Initiative (GHI) Consultation Document

The Administration released “Implementation of the Global Health Initiative: Consultation Document,” which includes specific goals and targets, core principles, and an operational plan for the Global Health Initiative (GHI).

USAID reports NTD treatment results

The U.S. Agency for International Development (USAID) released treatment results for the Neglected Tropical Disease (NTD) Control Program stating “that USAID funds for NTD control have enabled countries to provide more than 162 million treatments to more than 69 million people in Year 4 of the Program.”

Administration official discusses “Global Health and Foreign Policy”

In a speech titled “Global Health and Foreign Policy,” U.S. Representative to the Economic and Social Council of the United Nations Ambassador Rick Barton discussed the core principles of the Global Health Initiative (GHI) and stated “health is at the heart of the Millennium Development Goals [MDGs], and is essential to progress on poverty eradication, socio-economic development, primary education for all, gender equality, and partnering for development.”

CRS Report – Centers for Disease Control and Prevention Global Health Programs: FY2001-FY2011

From the report summary: “This report explains the role CDC plays in U.S. global health assistance, highlights how much the agency has spent on global health efforts from FY2001 to FY2010, and discusses how funding to each of its programs has changed during this period.”

Congressional letter urges USAID to provide funding for Research and Development (R&D) of new treatments for NTDs

In a letter to the United States Agency for International Development (USAID) Administrator Dr. Rajiv Shah, thirteen members of Congress expressed the need to expand U.S. government Neglected Tropical Diseases (NTD) initiatives to include all fifteen NTDs as designated by the World Health Organization (WHO), and urges “USAID to determine the best funding strategy to allow for proper resources to be devoted specifically to R&D for all NTDs.”

USAID Senior Deputy Assistant Administrator Gloria Steele testifies before the House Committee on Appropriations on the FY 2011 Global Health and Child Survival account budget request

During a House Committee on Appropriations, Subcommittee on State, Foreign Operations, and Related Programs hearing titled “Global Health and HIV/AIDS programs at the Department of State and the U.S. Agency for International Development,” USAID Senior Deputy Assistant Administrator Gloria Steele, testified on the FY 2011 Global Health and Child Survival (GHCS) account budget request. Topics covered in her testimony include: a breakdown of the FY 2011 budget request and program plans; health systems strengthening; integrating health programs; engaging with multilateral, nongovernmental, faith-based, and community based organizations; public-private partnerships; and research.

S. 3697 – Creating Hope Act of 2010

The proposed bill would amend the Food and Drug Administration (FDA) Amendments Act of 2007, which, among other things, established a “priority review voucher” entitling pharmaceutical companies that developed a treatment for tropical diseases to an expedited review of another drug by that company or sale of the voucher to another company. The proposed bill would allow for repeated transferability (or sale) of the priority review vouchers, expand voucher eligibility to include drug development for rare pediatric diseases, and add “Chagas Disease” to the classification of tropical diseases.